Technique | Regions of interest | Units reported | Precision (%CV) | Effective dose (μSv) |
---|---|---|---|---|
DXA | PA spine | BMD (g/cm2) | 1% | 1–10 |
Proximal femur | 1%–2% | 1–10 | ||
Total body | 1% | 3 | ||
QCT | Spine | BMD (g/cm3) | 3% | 50–500 |
pDXA | Forearm | BMD (g/cm2) | 1%–2% | 0.1 |
Calcaneus | 1%–2% | 0.1 | ||
pQCT | Forearm | BMD (g/cm3) | 1%–2% | 1–3 |
RA | Phalanx | BMD (g/cm2) | 1%–2% | 10 |
QUS | Calcaneus | BUA (dB/MHz) | 2%–5% | None |
Calcaneus | SOS (m/s) | 0.1%–1% | None | |
Tibia | SOS (m/s) | 1%–2% | None | |
Multisite | SOS (m/s) | 1%–2% | None |
PA = posteroanterior; BUA = broadband ultrasonic attenuation; SOS = speed of sound.